Your browser doesn't support javascript.
loading
Mutation in PIGA results in a CD52-negative escape variant in a Sézary syndrome patient during alemtuzumab treatment.
Halkes, Constantijn J M; Zoutman, Willem H; van der Fits, Leslie; Jedema, Inge; Vermeer, Maarten H.
Affiliation
  • Halkes CJM; Department of Hematology, University Medical Center Leiden, Leiden, The Netherlands. Electronic address: c.j.m.halkes@lumc.nl.
  • Zoutman WH; Department of Dermatology, University Medical Center Leiden, Leiden, The Netherlands.
  • van der Fits L; Department of Dermatology, University Medical Center Leiden, Leiden, The Netherlands.
  • Jedema I; Department of Hematology, University Medical Center Leiden, Leiden, The Netherlands.
  • Vermeer MH; Department of Dermatology, University Medical Center Leiden, Leiden, The Netherlands.
J Invest Dermatol ; 135(4): 1199-1202, 2015 Apr.
Article in En | MEDLINE | ID: mdl-25431852

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glycoproteins / Antigens, CD / Sezary Syndrome / Antibodies, Monoclonal, Humanized / Membrane Proteins / Mutation / Antigens, Neoplasm Type of study: Prognostic_studies Limits: Aged / Humans / Male Language: En Journal: J Invest Dermatol Year: 2015 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glycoproteins / Antigens, CD / Sezary Syndrome / Antibodies, Monoclonal, Humanized / Membrane Proteins / Mutation / Antigens, Neoplasm Type of study: Prognostic_studies Limits: Aged / Humans / Male Language: En Journal: J Invest Dermatol Year: 2015 Document type: Article
...